JMJD1C-AS1: A Promising Drug Target and Biomarker for the Treatment of Cancer

Target Name: JMJD1C-AS1

NCBI ID: G84989

Other Name(s): JMJD1C antisense RNA 1

JMJD1C-AS1: A Promising Drug Target and Biomarker for the Treatment of Cancer

Cancer is one of the leading causes of morbidity and mortality worldwide, with over 40% of the global cancer burden affecting the immune-system. The development of new treatments and their subsequent approval by regulatory authorities is crucial in the fight against cancer. One promising approach to cancer treatment is the use of small molecules, such as JMJD1C-AS1, which can inhibit the activity of JMJD1C, an enzyme involved in the production of the metabolite As1.

JMJD1C and its Metabolite As1

JMJD1C (Jumon), also known as human sphingomyelinase D1 (HSMD1), is an enzyme that

Protein Name: JMJD1C Antisense RNA 1

More Common Targets

AREAS

Q&A

STOCKS

TARGETS

CONTACT

BD@bio.cacnex.com